中华小儿外科杂志
中華小兒外科雜誌
중화소인외과잡지
CHINESE JOURNAL OF PEDIATRIC SURGERY
2013年
11期
843-847
,共5页
王光锋%陈鑫%董蒨%张虹%韩芦芦%鹿洪亭%郝希伟
王光鋒%陳鑫%董蒨%張虹%韓蘆蘆%鹿洪亭%郝希偉
왕광봉%진흠%동천%장홍%한호호%록홍정%학희위
神经母细胞瘤%微RNAs%细胞增殖%细胞凋亡
神經母細胞瘤%微RNAs%細胞增殖%細胞凋亡
신경모세포류%미RNAs%세포증식%세포조망
Neuroblastoma%MicroRNAs%Cell proliferation%Apoptosis
目的 探讨microRNA-92 (miR-92)对神经母细胞瘤细胞增殖的促进作用,并预测miR-92的靶基因.方法 人工设计合成miR-92的反义寡核苷酸(anti-miR-92寡核苷酸),利用脂质体LipofectamineTM 2000转染神经母细胞瘤SK-N-SH和SK-N-BE2细胞系,利用实时定量PCR检测转染后细胞内miR-92的表达水平,并通过噻唑蓝(MTT)比色法和流式细胞仪检测细胞的增殖和凋亡情况;利用生物信息学方法对miR-92的候选靶基因进行预测.结果 与对照组细胞相比,两种神经母细胞瘤细胞转染anti-miR-92后,miR-92的水平降低约70%,MTT检测细胞的活性降低约20%,流式分析仪检测发现增殖的细胞数降低约50%~60%,而细胞凋亡数增加约2~3倍,差异均具有统计学意义(P<0.05).通过生物信息学和对靶基因潜在功能分析,初步选定BCL2-like 11(BCL2L11)和phosphatase and tensin homolog deleted on chromosome ten (PTEN)作为是miR-92的候选靶基因.结论 抑制miR-92的表达导致神经母细胞瘤细胞的增殖降低,凋亡增加,从而可能进一步影响神经母细胞瘤的生长,miR-92可能具有作为临床上神经母细胞瘤治疗分子标记物的潜在功能,为以后更有意义的分子治疗奠定基础.
目的 探討microRNA-92 (miR-92)對神經母細胞瘤細胞增殖的促進作用,併預測miR-92的靶基因.方法 人工設計閤成miR-92的反義寡覈苷痠(anti-miR-92寡覈苷痠),利用脂質體LipofectamineTM 2000轉染神經母細胞瘤SK-N-SH和SK-N-BE2細胞繫,利用實時定量PCR檢測轉染後細胞內miR-92的錶達水平,併通過噻唑藍(MTT)比色法和流式細胞儀檢測細胞的增殖和凋亡情況;利用生物信息學方法對miR-92的候選靶基因進行預測.結果 與對照組細胞相比,兩種神經母細胞瘤細胞轉染anti-miR-92後,miR-92的水平降低約70%,MTT檢測細胞的活性降低約20%,流式分析儀檢測髮現增殖的細胞數降低約50%~60%,而細胞凋亡數增加約2~3倍,差異均具有統計學意義(P<0.05).通過生物信息學和對靶基因潛在功能分析,初步選定BCL2-like 11(BCL2L11)和phosphatase and tensin homolog deleted on chromosome ten (PTEN)作為是miR-92的候選靶基因.結論 抑製miR-92的錶達導緻神經母細胞瘤細胞的增殖降低,凋亡增加,從而可能進一步影響神經母細胞瘤的生長,miR-92可能具有作為臨床上神經母細胞瘤治療分子標記物的潛在功能,為以後更有意義的分子治療奠定基礎.
목적 탐토microRNA-92 (miR-92)대신경모세포류세포증식적촉진작용,병예측miR-92적파기인.방법 인공설계합성miR-92적반의과핵감산(anti-miR-92과핵감산),이용지질체LipofectamineTM 2000전염신경모세포류SK-N-SH화SK-N-BE2세포계,이용실시정량PCR검측전염후세포내miR-92적표체수평,병통과새서람(MTT)비색법화류식세포의검측세포적증식화조망정황;이용생물신식학방법대miR-92적후선파기인진행예측.결과 여대조조세포상비,량충신경모세포류세포전염anti-miR-92후,miR-92적수평강저약70%,MTT검측세포적활성강저약20%,류식분석의검측발현증식적세포수강저약50%~60%,이세포조망수증가약2~3배,차이균구유통계학의의(P<0.05).통과생물신식학화대파기인잠재공능분석,초보선정BCL2-like 11(BCL2L11)화phosphatase and tensin homolog deleted on chromosome ten (PTEN)작위시miR-92적후선파기인.결론 억제miR-92적표체도치신경모세포류세포적증식강저,조망증가,종이가능진일보영향신경모세포류적생장,miR-92가능구유작위림상상신경모세포류치료분자표기물적잠재공능,위이후경유의의적분자치료전정기출.
Objective To investigate the effects of miR-92 on the proliferation and apoptosis in human neuroblastoma (NB) cells,and to predict its putative targets.Methods Antisense oligonucleotides of miR-92 were synthesized and transfected into SK-N-SH and SK-N-BE2 cells,then real time PCR was performed for the detection of miR-92 expression.Cell proliferation and apoptosis were determined using MTT assay and flow cytometry.The putative targets for miR-92 were predicted using bioinformatics.Results Cell viability and proliferation of anti-miR-92 transfected cells were reduced by 20% and 50%-60%,respectively,while apoptosis increased by 2-3 fold (P<0.05).Using bioinformatics,BCL2-like 11 (apoptosis facilitator) (BCL2L11) and PTEN were selected as the candidate targets for miR-92.Conclusions Our data indicate that the inhibition of miR-92 can suppress NB cell proliferation and increase cell apoptosis,suggesting miR-92 may play important roles in NB growth.In addition,miR-92 may serve as a novel biomarker for therapeutic strategy of NB patients.